RobertKaplanMDAttending Physician

PubMed

• Cyclic Thrombocytopenia in the Setting of Intracranial Hemorrhage: A Diagnostic and Therapeutic Challenge.
  Ryan Sweeney, Maitreyee Rai, Harmeet Kharoud, Rama Bhagavatula, Robert Kaplan, Deep Shah> ;Journal of Hematology. 2023 Oct 1
• 7 citations
  COVID-19 mRNA-1273 vaccine induces production of vaccine-induced immune thrombotic thrombocytopenia antibodies.
  Anand Padmanabhan, Adam J Kanack, Robert B Kaplan, Swathi Sangli> ;American Journal of Hematology. 2022 Jun 1
• 11 citations
  A Case of COVID-19 Induced Thrombotic Thrombocytopenic Purpura
  Karthik Shankar, Deanna Huffman, Chelsea Peterson, Muhammad Yasir, Robert B. Kaplan> ;Cureus. 2021 Jul 11
• 5 citations
  Risk factors for venous thromboembolism in hospitalized patients with hematological malignancy: an analysis of the National Inpatient Sample, 2011-2015.
  Veli Bakalov, Amy Tang, Amulya Yellala, Robert B. Kaplan, John Lister, Santhosh Sadashiv> ;Leukemia & Lymphoma. 2020 Jan 28
• 4 citations
  Aggressive Disease and Rare Sequelae in a Unique Case of Atypical Hemolytic Uremic Syndrome Secondary to Adult Onset Still's Disease.
  Ahmed Khattab, Amulya Yellala, Jyothika Mamadgi, Sunita Patruni, Robert B. Kaplan> ;Journal of Hematology. 2019 Jul 6
• 6 citations
  Neisseria cinerea bacteremia in a patient receiving eculizumab: a case report.
  Thomas L. Walsh, Holly R. Bean, Robert B. Kaplan> ;Infection. 2018 Apr 1
• 29 citations
  Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.
  Rubens Costa, Salman Fazal, Robert B. Kaplan, Joel A. Spero, Ricardo Lima Barros Costa> ;Clinical Rheumatology. 2013 Mar 1
• 14 citations
  Post-transfusion purpura: a rare and life-threatening aetiology of thrombocytopenia
  Parikshit Padhi, Gulam Sadiq Parihar, Jason Stepp, Robert Kaplan> ;BMJ Case Reports. 2013 May 24
• US general population norms for telephone administration of the SF-36v2.
  Maglinte GA, Hays RD, Kaplan RM> ;J Clin Epidemiol. 2012-05-01
• Patient-reported measures of psychosocial issues and health behavior should be added to electronic health records.
  Glasgow RE, Kaplan RM, Ockene JK, Fisher EB, Emmons KM> ;Health Aff (Millwood). 2012-03-01
• Five preference-based indexes in cataract and heart failure patients were not equally responsive to change.
  Kaplan RM, Tally S, Hays RD, Feeny D, Ganiats TG, Palta M, Fryback DG> ;J Clin Epidemiol. 2011-05-01
• Behavior matters.
  Fisher EB, Fitzgibbon ML, Glasgow RE, Haire-Joshu D, Hayman LL, Kaplan RM, Nanney MS, Ockene JK> ;Am J Prev Med. 2011-05-01
• Health state preferences are equivalent in the United States and Trinidad and Tobago.
  Hector RD, Anderson JP, Paul RCP, Weiss RE, Hays RD, Kaplan RM> ;Qual Life Res. 2010-06-01
• A cost analysis of a physical activity intervention for older adults.
  Groessl EJ, Kaplan RM, Blair SN, Rejeski WJ, Katula JA, King AC, Fielding RA, Glynn NW, Pahor M> ;J Phys Act Health. 2009-11-01
• 5 citations
  Evaluation of an Internet-Based Disease Trajectory Decision Tool for Prostate Cancer Screening
  Vibha Bhatnagar, Dominick L. Frosch, Steven R. Tally, Charles J. Hamori, Leslie Lenert, Robert M. Kaplan> ;Value in Health. 2009 Jan 1
• Multivariate models of determinants of health-related quality of life in severe chronic obstructive pulmonary disease.
  Moy ML, Reilly JJ, Ries AL, Mosenifar Z, Kaplan RM, Lew R, Garshick E> ;J Rehabil Res Dev. 2009-01-01
• Living with hepatitis C: qualitative interviews with hepatitis C-infected veterans.
  Groessl EJ, Weingart KR, Kaplan RM, Clark JA, Gifford AL, Ho SB> ;J Gen Intern Med. 2008-12-01
• Health-related quality of life in emphysema.
  Kaplan RM, Ries AL> ;Proc Am Thorac Soc. 2008-05-01
• Evaluation of the validity of the Quality of Well-being Scale in Trinidad and Tobago.
  Hector RD, Anderson JP, Paul RCP, Ponce N, Hays RD, Weiss RE, Kaplan RM> ;West Indian Med J. 2008-03-01
• 73 citations
  Internet Patient Decision Support: A Randomized Controlled Trial Comparing Alternative Approaches for Men Considering Prostate Cancer Screening
  Dominick L. Frosch, Vibha Bhatnagar, Steven R. Tally, Charles J. Hamori, Robert M. Kaplan> ;Archives of Internal Medicine. 2008 Feb 25
• Quality of life: concept and definition.
  Kaplan RM, Ries AL> ;COPD. 2007-09-01
• Health-related quality of life in older adults at risk for disability.
  Groessl EJ, Kaplan RM, Rejeski WJ, Katula JA, King AC, Frierson G, Glynn NW, Hsu F, Walkup M, Pahor M> ;Am J Prev Med. 2007-09-01
• International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia.
  van de Garde EMW, Oosterheert JJ, Bonten M, Kaplan RC, Leufkens HGM> ;J Clin Epidemiol. 2007-08-01
• 11 citations
  Pre-operative management of a patient with hypoprothrombinemia-lupus anticoagulant syndrome
  Marion B. Raflores, Robert B. Kaplan, Joel A. Spero> ;Thrombosis and Haemostasis. 2007 Jun 7
• Should medicare reimburse providers for weight loss interventions?
  Kaplan RM> ;Am Psychol. 2007-04-01
• Join now to see all

Journal Articles

• Successful Plasma Exchange Combined with Rituximab Therapy in Aggressive APS-related Cutaneous Necrosis  
  Costa R, Fazal S, Kaplan R, Spero J, Costa R, Clin Rheumatology, 6/17/2010
• Preoperative Management of a Patient with Hypoprothrombinemia-Lupus Anticoagulant Syndrome  
  Raflores M., Kaplan R., Spero J, Thrombosis and Haemostasis, 1/1/2007
• Treatment of Acute Myelogenous Leukemia with Outpatient Azacitidine  
  Sudan N, Rossetti, JM, Shadduck RK, Latsko J, Lech JA, Kaplan R, Kennedy M, Gryn JF, Faroun Y and Lister J, American Cancer Society,Wiley Interscience, 1/1/2006
• Induction and Maintenance Therapy of Acute Myelogenous Leukemia with Outpatient Azacitidine  
  RK Sudan N, Rossetti JM, Shadduck RK, Lister J, Lech JA, Kaplan R, Kennedy MK, Faroun Y, Latsko J, Cancer, 1/1/2005
• Subcutaneous Lepirudin for Heparin-Induced Thrombocytopenia and When Other Anticoagulants Fail: Illustrative Cases  
  Steven R. Deitcher, MD, Raphael Ngengwe, Robert Kaplan MD, Howard Liebman,MD, Karen Kaplan, MD, Morey Binder, MD, Clinical Advances in Hematology & Oncology, 6/1/2004
• Combined Defect in Membrane Expression and Activation of Platelet GPIIb-IIIa Complex without Primary Sequence Abnormalities in Myeloproliferative Disease  
  R. Kaplan, J. Gabbeta, L. Sun, G. Mao, A.K. Rao, British Journal of Hematology, 1/1/2000
• Inherited Thrombophilic States  
  A.K. Rao, R. Kaplan, S. Sheth, Inherited Thrombophilic States, 1/1/1998
• Mechanisms of the Coagulopathy Associated with Acute Promyelocytic Leukemia  
  R. Kaplan, R. De la Cadena, American Journal of Hematology, 1/1/1998
• Inherited Hypercoagulable States  
  A K Rao, S Sheth, R. Kaplan, Vasc Med, 1/1/1997
• Join now to see all

Abstracts/Posters

• In-Hospital Complications and Outcomes of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Older Than 65-Years Old in the United States: National Inpa...
  Robert B. Kaplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Response to Azacitidine in patients with Secondary Myelodysplastic Syndrome
  Abdulhaq H, Rossetti JM, Shadduck RK, Lister J, Lech J, Kaplan R, Kennedy M, Latsko J, Kramer W, Journal of Clinical Oncology, 6/1/2006
• Response and Tolerability of a 5-day Azacitidine Schedule in Patients with Myelodysplastic Syndrome
  Abdulhaq H, Rossetti JM, Shadduck RK, Lister J, Lech JA, Kaplan R, Kennedy M, American Society of Clinical Oncology 2006 Annual Meeting, 1/1/2006
• Reduced Intensity Unrelated Peripheral Blood Stem Cell Transplant: Comparison of Two Regimens
  Raflores M, Rossetti JM, Kaplan R, Lech JA, Kennedy M, Schunn G, Shadduck RK, Lister J, National Marrow Donor Program (NMDP) Council Meeting, 11/1/2005
• Allogeneic and Matched Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies Using a Modified Reduced Intensity Conditioning Regimen
  Raflores M, Rossetti JM, Lister J, Shadduck RK, Lech J, Kaplan R, Kennedy M, Schunn G, Pennsylvania Society of Oncology and Hematology (PSOH) Annual Meeting, Harrisburg, PA, 9/1/2005
• AML Induction Therapy with Outpatient Azacitidine
  Shadduck RK, Rossetti JM, Faroun Y, Kaplan R, Lister J, 46th Annual Meeting of the American Society of Hematology, Blood, San Diego, CA, 12/1/2004
• AML Induction Therapy with Outpatient Azacitidine
  Shadduck RK, Rossetti JM, Faroun Y, Kaplan R, Lister J, Blood, 11/1/2004
• Impaired Iron Absorption in 2004
  Miske HR, Shadduck RK, Lister J, Kaplan R, Lech J, Kennedy M, Schunn, G, Rossetti JM, Pennsylvania Oncology and Hematology Society Meeting, Pittsburgh, PA, 9/1/2004
• Very Low Platelet Count in Post-Transfusion Purpura vs Heparin Induced Thrombocytopenia
  Faroun Y, Shadduck RK, Gryn JF, Kaplan R, Lieb J, Miske H, Pennsylvania Oncology and Hematology Society Meeting, Valley Forge, PA, 9/1/2003
• Lepirudin as Chronic Anticoagulation in Hypercoagulable Patients with Multiple Anticoagulant Failures: A Retrospective Case Series
  Miske H, Zeigler Z, Kaplan R, Pennsylvania Oncology and Hematology Society Meeting, Valley Forge, PA, 9/1/2003
• Reduced Intensity Peripheral Blood Stem Cell Transplant from Matched Related and Unrelated Donors
  Rossetti JM, Shadduck RK, Gryn JF, Zeigler ZR, Kaplan R, Lister J, The Western Pennsylvania Hospital Resident Research Day, 5/1/2003
• Whole Blood Aggregation and Measurement of Platelet Factor 3 Availability but Not Platelet-Rich Plasma Aggregation Studies Detects Platelet Function Abnormalities in P...
  R. Kaplan, Zella Rose Zeigler, Richard K. Shadduck, John Lister, Proceedings of the American Society of Hematology, 12/1/2002
• Paclitaxel by 1-hour Infusion Combined with Carboplatin in Advanced Non-small Cell Lung Carcinoma (NSCLC): A Phase II Study
  C Langer, R. Kaplan, E. Rosvold, M Millenson, MR Smith, C Johnson, R Kosierowski, C McAleer, C Bonjo, R Ozols, Proceedings of the American Society of Clinical Oncology, 5/1/1996
• Join now to see all

Lectures

• The Risk Factors of the Venous Thromboembolism in Hospitalized Patients with Hematologic Malignancies in the United States: National Inpatient Sample Analysis, 2011-2015 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Pharmacologic Approaches to the Management of Venous Thromboembolic Diseases and Heparin-Induced Thrombocytopenia 
  Buffalo, New York - 4/4/2007
• Advances in Anticoagulation for the Management of Venous Thromboembolic Disease and Heparin-Induced Thrombocytopenia 
  Johnstown, Pennsylvania - 10/11/2006
• Advances in Anticoagulation for the Management of Venous Thromboembolic Disease 
  Radisson Hotel, Monroeville, Pennsylvania - 10/7/2006
• Hypercoagulable Disorders: Part I-Hereditary 
  9/20/2006
• Blood in Motion 
  The Western Pennsylvania Hospital - 5/13/2006
• Evaluation of Thrombocytopenia/Bleeding Tendency 
  12/7/2005
• Diagnosis and Management of Common Types of Anemias 
  5/18/2005
• The Threat of DVT 
  The Western Pennsylvania Hospital - 5/14/2005
• Recognizing HIT in the ER Setting/The Role of Arixtra in Current Anticoagulation Management 
  Pittsburgh, Pennsylvania - 4/14/2005
• Berlex HIT (Heparin-Induced Thrombocytopenia) Speaker's Bureau 
  Canton, Ohio - 9/8/2004
• The Future of Refludan-Subcutaneous Dosing and Uses in non-HIT Settings 
  New Orleans, Louisiana - 6/6/2004
• The Future of Refludan-Subcutaneous Uses/The Western Pennsylvania Hospital Experience 
  The Ritz Carlton, Orlando, Florida - 3/13/2004
• Join now to see all